无管胰岛素帮浦市场 - 按最终用途（家庭护理、医院和诊所）、行业分析报告、区域展望、应用潜力、竞争市场份额和预测，2023 - 2032 年

由于人们对先进胰岛素输送方案和帮浦设计技术创新的认识不断提高，2023 年至 2032 年全球无管胰岛素帮浦市场CAGR将达到 19.2%。随着个人和医疗保健提供者越来越意识到简化和患者友好的解决方案，对无管胰岛素帮浦的需求将会激增。技术进步提供了增强的功能和用户便利性，进一步有助于市场扩张。不断提高的意识和持续创新之间的协同作用将使无管胰岛素帮浦成为不断发展的糖尿病照护领域的关键组成部分，推动市场的上升轨迹。

公司正积极致力于为糖尿病患者创造解决方案。这种对创新的承诺透过扩大先进和患者友善选择的范围、促进可及性和改善整体糖尿病护理来增强无管胰岛素帮浦市场。例如，2023 年，Insulet 正式推出 Omnipod 5 自动胰岛素输送系统，提供简化的血糖管理，无需每日多次注射、试管或指尖采血。

无管胰岛素帮浦产业根据最终用途和地区分为两部分。

在先进糖尿病管理技术在医疗保健环境中日益一体化的推动下，到 2032 年，医院和诊所的最终用途细分市场将获得显着的市场份额。随着医院和诊所优先考虑高效且患者友善的解决方案，对无管胰岛素帮浦的需求将会激增。医疗保健提供者在促进和实施创新糖尿病护理解决方案方面发挥关键作用，这将使该细分市场成为扩大无管胰岛素帮浦采用前景的主要贡献者。

亚太地区无管胰岛素帮浦市场将从 2023 年到 2032 年以显着的CAGR增长，原因是该地区糖尿病患病率不断上升、医疗基础设施不断发展以及对先进糖尿病管理技术的认识不断提高。由于无管胰岛素帮浦在胰岛素输送和连续血糖监测方面提供的便利性，对无管胰岛素帮浦的需求特别高。随着亚太地区的医疗保健系统优先考虑糖尿病护理，该地区将在塑造无管胰岛素帮浦产业的发展轨迹和扩张方面发挥关键作用。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：无内胎胰岛素帮浦产业见解

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 糖尿病盛行率上升
    • 无管胰岛素帮浦的技术进步
    • 增加糖尿病照护支出
    • 传统和侵入式胰岛素帮浦造成的伤害
    • 透过促进性倡议
  • 产业陷阱与挑战
    • 与无管胰岛素帮浦相关的高长期成本
    • 严格的政府法规
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
  • 我们
  • 欧洲
• 报销场景
• 技术景观
• 糖尿病的发生率和盛行率
• 管道分析
• 未来市场趋势
• 缺口分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 供应商矩阵分析
• 战略仪表板

第 5 章：无管胰岛素帮浦市场规模与预测：依最终用途

• 主要动向：依最终用途
• 居家护理
• 医院和诊所
• 其他的

第 6 章：无内胎胰岛素帮浦市场规模与预测：按地区

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
• 亚太地区
  • 日本
  • 中国
  • 澳洲
  • 韩国
• 排

第 7 章：公司简介

• Insulet Corporation
• Roche
• Medtrum Technologies
• Terumo Corporation
• Mannkind Corporation
• Terumo Corporation

Global Tubeless Insulin Pump Market will register a 19.2% CAGR from 2023 to 2032, propelled by increasing awareness of advanced insulin delivery options and technological innovations in pump design. As individuals and healthcare providers become more conscious of streamlined and patient-friendly solutions, demand for tubeless insulin pumps will surge. Technological advancements, offering enhanced features and user convenience, further contribute to market expansion. The synergy between rising awareness and continuous innovation will position tubeless insulin pumps as pivotal components in the evolving landscape of diabetes care, propelling the market's upward trajectory.

Companies are actively working on creating solutions for individuals with diabetes. This commitment to innovation enhances the tubeless insulin pump market by expanding the range of advanced and patient-friendly options, promoting accessibility, and improving overall diabetes care. For instance, in 2023, Insulet officially introduced the Omnipod 5 automated insulin delivery system, offering simplified glucose management without the need for multiple daily injections, tubes, or fingersticks.

The tubeless insulin pump industry is bifurcated based on end-use and region.

The hospitals and clinics end-use segment will achieve remarkable market share by 2032, driven by the increasing integration of advanced diabetes management technologies in healthcare settings. As hospitals and clinics prioritize efficient and patient-friendly solutions, the demand for tubeless insulin pumps will surge. The pivotal role of healthcare providers in promoting and implementing innovative diabetes care solutions will position this segment as a major contributor to the expanding landscape of tubeless insulin pump adoption.

Asia-Pacific tubeless insulin pump market will grow at a noteworthy CAGR from 2023 to 2032, attributed to the region's increasing prevalence of diabetes, growing healthcare infrastructure, and rising awareness about advanced diabetes management technologies. The demand for tubeless insulin pumps is notably high, driven by the convenience they offer in insulin delivery and continuous glucose monitoring. As healthcare systems in Asia-Pacific prioritize diabetes care, the region will play a pivotal role in shaping the trajectory and expansion of the tubeless insulin pump industry.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Tubeless insulin pump industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Regional trends
• 2.4 End-use trends

Chapter 3 Tubeless Insulin Pump Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of diabetes
    • 3.2.1.2 Technological advancements in tubeless insulin pump
    • 3.2.1.3 Increasing diabetes care expenditure
    • 3.2.1.4 Injuries caused by conventional & invasive insulin pumps
    • 3.2.1.5 Adoption of facilitative initiatives
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High long-term costs associated with tubeless insulin pump
    • 3.2.2.2 Stringent government regulations
• 3.3 Growth potential analysis
  • 3.3.1 By end-use
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Reimbursement scenario
• 3.7 Technology landscape
• 3.8 Incidence & prevalence of diabetes
• 3.9 Pipeline analysis
• 3.10 Future market trends
• 3.11 Gap analysis
• 3.12 Porter's analysis
• 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Company market share analysis, 2022
• 4.4 Competitive positioning matrix
• 4.5 Vendor matrix analysis, 2022
• 4.6 Strategy dashboard, 2022

Chapter 5 Tubeless Insulin Pump Market Size and Forecast, By End-use (USD Million)

• 5.1 Key trends, by end-use
• 5.2 Home care
• 5.3 Hospitals & clinics
• 5.4 Others

Chapter 6 Tubeless Insulin Pump Market Size and Forecast, By Region (USD Million)

• 6.1 Key trends, by region
• 6.2 North America
  • 6.2.1 U.S.
  • 6.2.2 Canada
• 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 UK
  • 6.3.3 France
  • 6.3.4 Spain
  • 6.3.5 Italy
• 6.4 Asia Pacific
  • 6.4.1 Japan
  • 6.4.2 China
  • 6.4.3 Australia
  • 6.4.4 South Korea
• 6.5 RoW

Chapter 7 Company Profiles

• 7.1 Insulet Corporation
• 7.2 Roche
• 7.3 Medtrum Technologies
• 7.4 Terumo Corporation
• 7.5 Mannkind Corporation
• 7.6 Terumo Corporation

Data Tables

• TABLE 1. Product mapping
• TABLE 2. Market share, by end-use (2022)
• TABLE 3. Market share, by region (2022)
• TABLE 4. Global tubeless insulin pump market size, 2018 - 2024 (USD Million)
• TABLE 5. Global tubeless insulin pump market size, 2025 - 2032 (USD Million)
• TABLE 6. Global tubeless insulin pump market, by region, 2018 - 2024 (USD Million)
• TABLE 7. Global tubeless insulin pump market, by region, 2025 - 2032 (USD Million)
• TABLE 8. Global tubeless insulin pump market, by end-use, 2018 - 2024 (USD Million)
• TABLE 9. Global tubeless insulin pump market, by end-use, 2025 - 2032 (USD Million)
• TABLE 10. Industry impact forces
• TABLE 11. Home care market size, 2018 - 2024 (USD Million)
• TABLE 12. Home care market size, 2025 - 2032 (USD Million)
• TABLE 13. Hospitals & clinics care market size, 2018 - 2024 (USD Million)
• TABLE 14. Hospitals & clinics care market size, 2025 - 2032 (USD Million)
• TABLE 15. Others market size, 2018 - 2024 (USD Million)
• TABLE 16. Others market size, 2025 - 2032 (USD Million)
• TABLE 17. North America tubeless insulin pump market size, by country, 2018 - 2024 (USD Million)
• TABLE 18. North America tubeless insulin pump market size, by country, 2025 - 2032 (USD Million)
• TABLE 19. North America tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 20. North America tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 21. U.S. tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 22. U.S. tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 23. Canada tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 24. Canada tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 25. Europe tubeless insulin pump market size, by country, 2018 - 2024 (USD Million)
• TABLE 26. Europe tubeless insulin pump market size, by country, 2025 - 2032 (USD Million)
• TABLE 27. Europe tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 28. Europe tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 29. Germany tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 30. Germany tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 31. UK tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 32. UK tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 33. France tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 34. France tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 35. Spain tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 36. Spain tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 37. Italy tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 38. Italy tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 39. Asia Pacific tubeless insulin pump market size, by country, 2018 - 2024 (USD Million)
• TABLE 40. Asia Pacific tubeless insulin pump market size, by country, 2025 - 2032 (USD Million)
• TABLE 41. Asia Pacific tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 42. Asia Pacific tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 43. China tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 44. China tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 45. Japan tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 46. Japan tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 47. Australia tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 48. Australia tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 49. South Korea tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 50. South Korea tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 51. RoW tubeless insulin pump market size, by country, 2018 - 2024 (USD Million)
• TABLE 52. RoW tubeless insulin pump market size, by country, 2025 - 2032 (USD Million)
• TABLE 53. RoW tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 54. RoW tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Industry segmentation
• FIG. 3 Top-down approach
• FIG. 4 Market estimation and forecast methodology
• FIG. 5 Market forecasting methodology
• FIG. 6 Breakdown of primary participants
• FIG. 7 Tubeless insulin pump industry 360 degree synopsis, 2018 - 2032
• FIG. 8 Industry ecosystem analysis
• FIG. 9 Growth potential analysis, by end-use
• FIG. 10 Porter's analysis
• FIG. 11 PESTEL analysis
• FIG. 12 Company matrix analysis, 2022
• FIG. 13 Vendor matrix analysis
• FIG. 14 Global company market share analysis, 2022
• FIG. 15 Competitive positioning matrix
• FIG. 16 Strategy dashboard, 2022